It has been suggested that upregulation of BCL6 by TKIs is responsible for the maintenance of CML stem cells through FOXO3a signaling and by repressing Arf and p53 18. This evidence concerns the gene CDKN2A and chronic myelogenous leukemia, BCR-ABL1 positive.